CASTLEMAN'S DISEASE: HYPERPLASIA RESEMBLING A NEOPLASIA
Keywords:
Castleman 's disease, angifollicular lymph nade hyperplasia, Endometriat neoplasms, POEMS syndromeAbstract
Castleman's disease can presenta wide variety of biological behaviors, each with its own distinct treatment and prognosis. Generally, there is an association among microscopy, clinica/ presentation and individual prognosis. Clinically, this disease is divided into solitary and multicentric forms; cure of the solitary form is possible with surgical excision while the multicentric form has a more guarded prognosis in the long run. An atypical presentation is described with an indolent clinica/ progress and good prognosis. Current concepts on Castleman's disease and important differential diagnoses are also discussed.
Downloads
References
Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology & genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p.157-60.
Hamilton SR, Aaltonen LA. Pathology & genetics of tumours of the digestive system. Lyon: IARC Press; 2001. p.57-61.
Guillem P, Karoui M, Deroide G, Herjean M, Leteurtre E, Triboulet JP. Maladie de Castleman de localisation mésentérique. Gastroenterol Clin Biai. 2000; 24(1):116-22.
Strauchen JA, Diagnostic histopathology of the lymph nade. New York: Oxford University Press; 1998. p.142-52.
Dispenzieri A, Gertz MA. Treatment of Castleman's disease. Curr Treat Options Oncol. 2005; 6(3): 255-66.
Sun T, Susin M. Differential diagnosis of lymphoid disorders. New York: lgaku-Shoin Medical Puplishers; 1996. p.82-9.
An J, Lichtenstein AK, Brent G, Retting MB.The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood. 2002; 99(2):649-54.
Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, et ai. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005; 106(8):2628-32.
Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et ai. POEMS syndrome: definition and long-term outcome. Blood. 2003; 101(7):2496-506.
Aoki Y, Tosato G, Fonville TW, Pittaluga S. Serum virai interleukin-6 in AIDS-related multicentric Castleman disease. Blood. 2001; 97(8):2526-7.
Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabecadas J, et ai. KSHV- and EBV- associated germinotropic lymphoproliferative disorder. Blood. 2002; 100(9):3415-8.
Marcelin AG, Aaron L, Mateus C, Gyan E, Gorin 1, Viard JP, et ai. Rituximab therapy for HIV-associated Castleman disease. Blood. 2003; 102(8):2786-8.
Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, et ai. High incidence of Kaposi sarcoma-associated herpesvirus-related non Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood. 2002; 99(7):2331-6.
Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, et ai. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood. 2001; 98(12):3473-5.
